Results 171 to 180 of about 37,376 (216)

Editorial: HTLV-1 and EBV-related disorders: pathogenesis and clinical advances. [PDF]

Front Med (Lausanne)
Miyashiro D, Casseb J, Sugaya M, Yasui H, Sanches JA.   +4 more
europepmc   +1 more source

Strongyloidiasis Beyond the Tropics: Updated Epidemiological Evidence from a Historically Endemic Region in Spain. [PDF]

Trop Med Infect Dis
de Castro-Oliver A, Guevara-Hernández P, Guillem J, Moret-Paredes M, Marco-Gabarre A, Lucas-Camps A, Prades-Sirvent C, Ruiz-Raga D, Ventura Esteve A, Perea Ribis MA, Llopis Sanchis M, Izquierdo García E, Ghukasyan H, Pallás Cervera M, Visconti Martín C, López Amorós AI, Gómez Uranga A, Vela-Bernal S, de Gracia-Leon AI, Belmonte-Domingo A, Pinto-Pla C, Ferrer-Ribera A, Corma-Gómez A, Galindo MJ, Oltra-Sempere MR, Belizón B, Forner MJ, Navarro D, Corrales I, Bea-Serrano C.   +29 more
europepmc   +1 more source

Seroprevalence of HTLV-½ in Macapá-AP, Brazil, in general population. [PDF]

Rev Soc Bras Med Trop
Silva ALD, Folgosi VÂ, Casseb JSDR, Rego MODS, Mendes DDS, Marques JP, Ribeiro ESD, Costa ACD, Sabino EC, Romano CM.   +9 more
europepmc   +1 more source

Coincidental Coexistence of Human T-lymphotropic Virus Type 1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis and Myasthenia Gravis in a Patient With Chronic HTLV-1 Infection: A Case Report. [PDF]

Cureus
Garma-Solis IJ, Zapata-Arceo FS, Ayuso-Diaz VM, Moreno-Enriquez A.   +3 more
europepmc   +1 more source

A case of lower respiratory tract infection caused by <i>Pandoraea sputorum</i> in a human T-lymphotropic virus type 1 carrier. [PDF]

IDCases
Ogasawara T, Yamanda S, Fukuzawa K, Yamazaki Y, Doman T, Minami S, Narumi A, Saito S, Odaka T, Ono K, Shimizu H, Sugisaka J, Aiba T, Kawana S, Toi Y, Sugawara S, Kimura Y.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Signs and symptoms of human T‐lymphotropic virus 1 and 2 infections in paediatric patients

Tropical Medicine & International Health, 2023
AbstractObjectiveTo determine the prevalence of signs and symptoms of HTLV‐1 and 2 infection in paediatric patients.MethodsWe included cohort, case‐control and descriptive observational studies that reported the prevalence of signs and symptoms of HTLV‐1 and 2 infections in paediatric patients.
Christian Andrés Rojas Cerón, Deigober Galvis Arias, Herney Andrés García‐Perdomo   +2 more
openaire   +2 more sources

Human T Lymphotropic Virus 1-Associated Myelopathy: Overview of Human T Cell Lymphotropic Virus-1/2 Tests and Potential Biomarkers

AIDS Research and Human Retroviruses, 2022
Human T cell lymphotropic virus (HTLV)-1-associated myelopathy is a chronic, disabling inflammatory disorder of the spinal cord caused by HTLV-1 infection. The diagnosis of HTLV-1-associated myelopathy (HAM) is based on clinical and laboratorial findings.
Marzia Puccioni-Sohler, André Rodrigues Poton, Mauro Jorge Cabral-Castro, Yoshihisa Yamano, Graham Taylor, Jorge Casseb   +5 more
openaire   +2 more sources

Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden

Scandinavian Journal of Infectious Diseases, 2012
Prevalence data on human T-lymphotropic virus types 1 and 2 (HTLV-1/2) in Sweden have not been updated since 1995. The seroprevalence among blood donors at that time was 0.2/10,000. A few years earlier, a high prevalence of HTLV-2 was found in intravenous drug users (IDUs) in Stockholm (3.4%).
Kerstin, Malm, Bengt, Ekermo, Kristina, Hillgren, Sven, Britton, Hans, Fredlund, Sören, Andersson   +5 more
openaire   +2 more sources